ACA preventive care means the services the Affordable Care Act requires most private health plans to cover with no copay, deductible, or coinsurance, even before you meet your deductible, as long as you see an in-network provider. The list is set by four expert bodies and currently includes about 100 distinct service categories, from blood pressure screening to colonoscopy to depression screening. The catch: a related diagnosis often triggers a bill, and the rules do not apply to short-term plans or grandfathered policies.
The mechanism: how a screening becomes free
The ACA does not list services itself. It delegates to four independent expert bodies: the U.S. Preventive Services Task Force (USPSTF), the Advisory Committee on Immunization Practices (ACIP), the Health Resources and Services Administration (HRSA) for women and children, and the Bright Futures program for pediatric care. A service becomes a mandate when one of these bodies issues a grade A or B recommendation, or a routine recommendation in the immunization and women's-health tracks.
The mandate binds non-grandfathered private plans in the individual, small-group, and large-group markets. That includes most employer plans and every marketplace plan. It does not bind short-term limited-duration plans, health care sharing ministries, or grandfathered plans. Medicare Part B already covered many screenings before 2010 but gained first-dollar coverage for the ACA list. Medicaid expansion states follow the same recommendations, though enforcement varies.
The free part is specific. Regulators require coverage of the screening with no cost sharing when delivered by an in-network provider. The billing only breaks when something happens beyond the screening itself. The most important distinction: a service that is preventive stays free, but a visit that turns diagnostic stops being free. That single rule explains most surprise bills.
In plain terms: the test is free, but the conversation about why you need the test can cost you.
What is actually covered, by body domain
Coverage spans nearly every organ system, and each domain carries its own frequency rules and thresholds. The numbers below follow the current USPSTF, HRSA, and ACIP recommendations as of late 2026.
Cardiovascular and metabolic. Blood pressure screening is covered at every routine visit with no age floor in many plans. Lipid screening for adults with risk factors starts at 20 and repeats every 4 to 6 years. Statin therapy for primary prevention is covered for adults aged 40 to 75 with at least one risk factor and a 10-year cardiovascular risk of 10 percent or higher, per the 2022 USPSTF recommendation. Diabetes screening begins at 35 for adults with overweight or obesity and repeats every 3 years.
Cancer. Colorectal cancer screening runs from age 45 to 75, with the frequency depending on the method: a colonoscopy every 10 years, or a stool-based test every 1 to 3 years. Breast cancer screening is recommended every 2 years for women aged 40 to 74, a change the USPSTF finalized in 2024 after years of starting at 50. Cervical cancer screening begins at 21 with a Pap test every 3 years, or at 25 with primary HPV testing every 5 years. Lung cancer screening applies to adults 50 to 80 with a 20 pack-year smoking history who currently smoke or quit within 15 years, done annually with low-dose CT.
Infectious disease. Adult vaccination is covered under the ACIP track, including influenza annually, COVID-19 updates, shingles at 50, and pneumococcal vaccines at 50 or 65 depending on risk. HIV screening is covered once for everyone aged 15 to 65. Hepatitis B and C screening are covered once for adults, with repeat testing for higher-risk groups.
Mental health and substance use. Depression screening is covered for all adults, and anxiety screening for adults under 65. Alcohol misuse screening comes with brief counseling, and tobacco cessation counseling plus FDA-approved medication is covered with no cost sharing. The tobacco benefit is one of the few that pays for drugs, not just a test.
Reproductive and maternal health. The HRSA women's track covers contraception (every FDA-approved method), breastfeeding support and supplies, and gestational diabetes screening. Preeclampsia screening with blood pressure and urine testing is covered during pregnancy. Well-woman visits are covered annually.
Vision, hearing, and pediatric care. Bright Futures covers vision screening at set ages, hearing screening for newborns and children, and developmental screening at 9, 18, and 30 months. Autism screening is covered at 18 and 24 months.
The frequency timeline: when each screening becomes free
Screening intervals are not arbitrary. Each one reflects the balance between detection benefit and the harm and cost of over-testing. The table below sets out the typical adult sequence.
| Age band | Flagship covered screening | Interval |
|---|---|---|
| 15-21 | HIV, cervical (from 21), depression | Once or every 3 years |
| 25-39 | Cervical HPV, blood pressure, lipids for risk | Every 3-5 years depending on test |
| 40-49 | Breast (from 40), statin risk assessment, colorectal (from 45) | Every 2 years, one-time risk, then interval |
| 50-64 | Colorectal, lung (if eligible), shingles, pneumococcal | 1-10 years by test |
| 65-75 | Colorectal, breast, bone density (from 65) | 2-10 years |
| 75 and up | Case-by-case; many screenings stop | Individual decision |
The timeline hides an important trap. The age windows are recommendations, not guarantees. A plan must cover the service when ordered at the recommended age, but the patient and clinician decide whether the screen is appropriate. A screening done outside the recommended window may be covered or may not be, depending on the plan's medical-necessity review.
The comparison that matters: preventive vs diagnostic billing
The largest source of surprise bills in ACA preventive care is a coding change, not a coverage gap. When a screening turns up an abnormality and the provider investigates it in the same visit, the visit can be reclassified from preventive to diagnostic. The patient then owes cost sharing that the preventive rule was meant to eliminate.
| Scenario | Billing code type | Patient cost |
|---|---|---|
| Routine colonoscopy, no polyp | Preventive | USD 0 |
| Colonoscopy with polyp removed | Often diagnostic | Copay plus deductible possible |
| Screening mammogram, normal | Preventive | USD 0 |
| Diagnostic mammogram for a lump | Diagnostic | Coinsurance applies |
| Annual physical, no new problem | Preventive | USD 0 |
| Physical plus discussion of a new symptom | Split or diagnostic | Copay possible |
The rule to reconcile: a polyp found during a screening colonoscopy does not automatically make the service diagnostic. A federal clarification in 2021 pushed insurers to treat the removal of a polyp discovered during a screening as part of the screening, but enforcement is uneven. Some plans still bill a diagnostic code, which can move a patient from a USD 0 visit to several hundred dollars owed before the deductible.
Non-obvious edge cases that break the free guarantee
Three situations account for most complaints, and none of them is a loophole in the law itself.
Genetic counseling and testing. BRCA testing is covered for women with a personal or family history suggesting elevated risk, but the screening rule covers counseling and the test only when criteria are met. A test ordered without documented criteria can be denied as not medically necessary.
Out-of-network care. The preventive rule protects in-network care. A screening done by an out-of-network lab, or a colonoscopy by an out-of-network anesthesiologist, can trigger balance billing. The No Surprises Act narrowed this gap for emergency and ancillary services in 2022, but the patient can still receive a bill when the plan's network is narrow.
Contraception confusion. The HRSA women's track requires coverage of at least one form of every FDA-approved contraceptive method with no cost sharing. Plans that cover only generics but not the branded version a clinician deems medically necessary can be challenged, and the patient may need to file an appeal.
Red flags that a preventive bill is wrong
If a bill or Explanation of Benefits arrives for something you believe should be free, the following signs suggest a coding error rather than a genuine charge:
- The service name says screening or preventive but the code begins with a diagnostic series, not a Z00-Z13 preventive code.
- The charge is for a service inside the plan's recommended age and frequency window.
- The provider was in network and no abnormality was found or treated.
- The bill lists a separate anesthesiologist or lab fee for a screening procedure.
- The Explanation of Benefits shows a deductible applied to a service the plan's own summary says is covered at 100 percent.
- You were seen for a well-visit but the provider added a symptom code to the same encounter.
Any one of these is grounds to call the insurer and ask for a coding review. The Patient Protection provision requires internal appeals within 180 days and external review if the internal appeal fails.
What to actually do before your next visit
Concrete steps reduce the odds of a surprise bill more than any single plan feature.
First, download the plan's preventive services summary, which federal rules require insurers to publish, and check the frequency limit for the specific test you are due for. Second, confirm that the provider, the lab, and any anesthesia group are in network, because the preventive rule only protects in-network care. Third, when scheduling, ask the office to code the visit as preventive and to tell you in advance if a diagnostic add-on is possible. Fourth, keep the screening separate from problem visits where practical. Fifth, if a bill arrives, request the medical records and the exact billing codes before paying anything.
Limitations and what the mandate does not do
The ACA preventive care rule is powerful but bounded. It does not create a right to every test a patient wants, and it does not control what a provider charges before insurance adjusts the bill. It does not cover diagnostic follow-up at zero cost, which is why the annual number of surprise bills for screening-related follow-up remains a persistent complaint. And it does not apply to the roughly 10 to 15 percent of privately insured people still in grandfathered plans or short-term coverage.
The mandate is also administratively fragile. Coverage depends on the recommendations of four bodies that update on their own schedules, and a recommendation change can add or remove a benefit with little notice. The 2024 breast cancer age change is the clearest recent example. The lesson for patients is to treat the preventive list as a living document, check it before each screening cycle, and know that the free part ends precisely where the screening ends and diagnosis begins.